Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Cash flows from operating activities:
Net income	$ 310,693	$ 335,077
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	83,151	66,692
Amortization of intangibles	108,717	36,787
Cost of goods sold for inventory acquired	121,113	0
Stock-based compensation expense	39,015	31,568
Loss on extinguishment of debt	0	3,290
Excess tax benefit-stock options	(25,953)	(4,198)
Deferred income taxes	(87,035)	(7,178)
Other non-cash activity	24,149	1,244
Changes in operating assets and liabilities	262,106	76,626
Total adjustments	525,263	204,831
Net cash provided by operating activities	835,956	539,908
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(705,448)	(3,571,764)
Maturities of short-term available-for-sale investments	3,091,873	2,932,226
Sales of short-term available-for-sale investments	357,388	150,266
Additions to property, plant and equipment	(75,266)	(48,645)
Payments for acquisitions, net of cash acquired	(9,687,533)	(2,203)
Changes in other assets	(12,063)	(9,457)
Net cash used for investing activities	(7,031,049)	(549,577)
Cash flows from financing activities:
Early termination of debt	0	(378,156)
Payments of derivative instruments	0	(33,430)
Proceeds from debt	11,156,164	1,235,331
Payments of deferred financing fees	(5,625)	0
Proceeds from derivative instruments	3,904	0
Dividend payments to shareholders	(268,997)	(254,583)
Repurchase of common stock	(26,980)	(345,627)
Proceeds from employee stock plans	87,273	22,709
Changes in other financing activities	(16)	(5,330)
Excess tax benefit-stock options	25,953	4,198
Net cash provided by financing activities	10,971,676	245,112
Effect of exchange rate changes on cash	28	(134)
Net increase in cash and cash equivalents	4,776,611	235,309
Cash and cash equivalents at beginning of period	921,132	884,353
Cash and cash equivalents at end of period	$ 5,697,743	$ 1,119,662